Internal Med

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Katoh N - In this review, the limitations of the currently available therapies and the advantages and disadvantages of new approaches for the treatment of atopic dermatitis including topical and systemic immunosuppressants as well as biologics and anti-pruritic agents are discussed. Potential new cellular targets for the treatment of atopic dermatitis are also illustrated.

Today in Allergy/Immunology...keeping you current

Effects of endogenous glucocorticoids on allergic inflammation and TH1/TH2 balance in airway allergic disease
Annals of Allergy, Asthma, and Immunology, 12/18/09

Temperature modulated histamine-itch in lesional and nonlesional skin in atopic eczema a combined psychophysical and neuroimaging study
Allergy, 12/18/09

Anti-TNF-[alpha] therapy with infliximab in spondyloarthritides
Expert Review of Clinical Immunology, 12/17/09

Today in Dermatology...keeping you current

Juvenile bullous pemphigoid: the presentation and follow-up of six cases
Journal of the European Academy of Dermatology and Venereology, 12/18/09

Is there any relation between serum insulin and insulin-like growth factor-I in non-diabetic patients with skin tag
Journal of the European Academy of Dermatology and Venereology, 12/18/09

Somatostatin receptor scintigraphy in primary cutaneous T- and B-cell lymphomas
Journal of the European Academy of Dermatology and Venereology, 12/18/09